{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:39:29Z","timestamp":1778884769935,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s40256-022-00554-5","type":"journal-article","created":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T17:04:38Z","timestamp":1667235878000},"page":"77-87","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Antithrombotic Strategy in Secondary Prevention for High-Risk Patients with Previous Acute Coronary Syndrome: Overlap between the PEGASUS Eligibility and the COMPASS Eligibility in a Large Multicenter Registry"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7903-4873","authenticated-orcid":false,"given":"Michele","family":"Millesimo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edoardo","family":"Elia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Marengo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ovidio","family":"De Filippo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Raposeiras-Roubin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"Wa\u0144ha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emad","family":"Abu-Assi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Kinnaird","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Ariza-Sol\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Liebetrau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Manzano-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Iannaccone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Paulo Simao","family":"Henriques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Templin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen B.","family":"Wilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lazar","family":"Velicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioanna","family":"Xanthopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Correia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Cerrato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Rognoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iv\u00e1n","family":"Nu\u00f1ez-Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiantao","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuma","family":"Kawaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Quadri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zenon","family":"Huczek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael Cobas","family":"Paz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Ram\u00f3n Gonz\u00e1lez","family":"Juanatey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shao-Ping","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masa-aki","family":"Kawashiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Dominguez-Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Conrotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"D\u2019Ascenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaetano Maria","family":"De Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,31]]},"reference":[{"issue":"42","key":"554_CR1","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1093\/eurheartj\/ehw334","volume":"37","author":"N Townsend","year":"2016","unstructured":"Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, Nichols M. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J. 2016;37(42):3232\u201345.","journal-title":"Eur Heart J"},{"issue":"12","key":"554_CR2","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1001\/jama.2010.1322","volume":"304","author":"DL Bhatt","year":"2010","unstructured":"Bhatt DL, Eagle KA, Ohman EM, et al. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. JAMA. 2010;304(12):1350.","journal-title":"JAMA"},{"issue":"7","key":"554_CR3","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.amjmed.2014.12.007","volume":"128","author":"SMA Alnasser","year":"2015","unstructured":"Alnasser SMA, Huang W, Gore JM, et al. Late consequences of acute coronary syndromes: global registry of acute coronary events (GRACE) follow-up. Am J Med. 2015;128(7):766\u201375.","journal-title":"Am J Med"},{"key":"554_CR4","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ahj.2019.10.001","volume":"220","author":"F D\u2019Ascenzo","year":"2020","unstructured":"D\u2019Ascenzo F, Biol\u00e8 C, Raposeiras-Roubin S, et al. Average daily ischemic versus bleeding risk in patients with ACS undergoing PCI: insights from the BleeMACS and RENAMI registries. Am Heart J. 2020;220:108\u201315.","journal-title":"Am Heart J"},{"issue":"19","key":"554_CR5","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1093\/eurheartj\/ehu505","volume":"36","author":"T Jernberg","year":"2015","unstructured":"Jernberg T, Hasvold P, Henriksson M, Hjelm H, Thuresson M, Janzon M. Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective. Eur Heart J. 2015;36(19):1163\u201370.","journal-title":"Eur Heart J"},{"issue":"3","key":"554_CR6","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1056\/NEJMoa1002358","volume":"364","author":"GW Stone","year":"2011","unstructured":"Stone GW, Maehara A, Lansky AJ, et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011;364(3):226\u201335.","journal-title":"N Engl J Med"},{"issue":"12","key":"554_CR7","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1161\/CIRCRESAHA.114.302737","volume":"114","author":"DL Bhatt","year":"2014","unstructured":"Bhatt DL, Hulot J-S, Moliterno DJ, Harrington RA. Antiplatelet and anticoagulation therapy for acute coronary syndromes. Circ Res. 2014;114(12):1929\u201343.","journal-title":"Circ Res"},{"key":"554_CR8","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/eurheartj\/ehv443","volume":"2","author":"JA Udell","year":"2015","unstructured":"Udell JA, Bonaca MP, Collet J-P, et al. Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials. Eur Heart J. 2015;2:443.","journal-title":"Eur Heart J"},{"issue":"20","key":"554_CR9","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1016\/j.jacc.2015.03.003","volume":"65","author":"RW Yeh","year":"2015","unstructured":"Yeh RW, Kereiakes DJ, Steg PG, et al. Benefits and risks of extended duration dual antiplatelet therapy after PCI in patients with and without acute myocardial infarction. J Am Coll Cardiol. 2015;65(20):2211\u201321.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"554_CR10","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1177\/2047487319836327","volume":"27","author":"F D\u2019Ascenzo","year":"2020","unstructured":"D\u2019Ascenzo F, Bertaina M, Fioravanti F, et al. Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry. Eur J Prev Cardiol. 2020;27(7):696\u2013705.","journal-title":"Eur J Prev Cardiol"},{"issue":"19","key":"554_CR11","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","volume":"372","author":"MP Bonaca","year":"2015","unstructured":"Bonaca MP, Bhatt DL, Cohen M, et al. Long-term use of ticagrelor in patients with prior myocardial infarction. N Engl J Med. 2015;372(19):1791\u2013800.","journal-title":"N Engl J Med"},{"issue":"14","key":"554_CR12","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","volume":"377","author":"JW Eikelboom","year":"2017","unstructured":"Eikelboom JW, Connolly SJ, Bosch J, et al. Rivaroxaban with or without aspirin in stable cardiovascular disease. N Engl J Med. 2017;377(14):1319\u201330.","journal-title":"N Engl J Med"},{"issue":"1","key":"554_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/ehjcvp\/pvz048","volume":"6","author":"O De Filippo","year":"2020","unstructured":"De Filippo O, D\u2019Ascenzo F, Raposeiras-Roubin S, et al. P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects. Eur Heart J Cardiovasc Pharmacother. 2020;6(1):31\u201342.","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"20","key":"554_CR14","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1016\/j.jacc.2014.09.008","volume":"64","author":"A Colombo","year":"2014","unstructured":"Colombo A, Chieffo A, Frasheri A, et al. Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy. J Am Coll Cardiol. 2014;64(20):2086\u201397.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"554_CR15","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s40520-016-0662-y","volume":"29","author":"G Campo","year":"2017","unstructured":"Campo G, Pavasini R, Maietti E, et al. The frailty in elderly patients receiving cardiac interventional procedures (FRASER) program: rational and design of a multicenter prospective study. Aging Clin Exp Res. 2017;29(5):895\u2013903.","journal-title":"Aging Clin Exp Res"},{"issue":"10270","key":"554_CR16","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0140-6736(20)32519-8","volume":"397","author":"F D\u2019Ascenzo","year":"2021","unstructured":"D\u2019Ascenzo F, De Filippo O, Gallone G, et al. Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets. Lancet. 2021;397(10270):199\u2013207.","journal-title":"Lancet"},{"issue":"6","key":"554_CR17","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999;130(6):461.","journal-title":"Ann Intern Med"},{"issue":"23","key":"554_CR18","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","volume":"123","author":"R Mehran","year":"2011","unstructured":"Mehran R, Rao SV, Bhatt DL, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium. Circulation. 2011;123(23):2736\u201347.","journal-title":"Circulation"},{"issue":"23","key":"554_CR19","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","volume":"371","author":"L Mauri","year":"2014","unstructured":"Mauri L, Kereiakes DJ, Yeh RW, et al. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med. 2014;371(23):2155\u201366.","journal-title":"N Engl J Med"},{"issue":"1","key":"554_CR20","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1161\/CIRCULATIONAHA.114.013570","volume":"131","author":"KN Garratt","year":"2015","unstructured":"Garratt KN, Weaver WD, Jenkins RG, et al. Prasugrel plus aspirin beyond 12 months is associated with improved outcomes after taxus libert\u00e9 paclitaxel-eluting coronary stent placement. Circulation. 2015;131(1):62\u201373.","journal-title":"Circulation"},{"issue":"42","key":"554_CR21","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1093\/eurheartj\/ehx437","volume":"38","author":"F D\u2019Ascenzo","year":"2017","unstructured":"D\u2019Ascenzo F, Iannaccone M, Saint-Hilary G, et al. Impact of design of coronary stents and length of dual antiplatelet therapies on ischaemic and bleeding events: a network meta-analysis of 64 randomized controlled trials and 102 735 patients. Eur Heart J. 2017;38(42):3160\u201372.","journal-title":"Eur Heart J"},{"issue":"9678","key":"554_CR22","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","volume":"373","author":"Antithrombotic Trialists\u2019 (ATT) Col","year":"2009","unstructured":"Antithrombotic Trialists\u2019 (ATT) Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009;373(9678):1849\u201360.","journal-title":"Lancet"},{"issue":"9038","key":"554_CR23","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","volume":"348","author":"CAPRIE Steering Committee","year":"1996","unstructured":"CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348(9038):1329\u201339.","journal-title":"Lancet"},{"issue":"9","key":"554_CR24","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1111\/bcp.13291","volume":"83","author":"P Blin","year":"2017","unstructured":"Blin P, Dureau-Pournin C, Lassalle R, et al. Outcomes in patients after myocardial infarction similar to those of the PEGASUS-TIMI 54 trial: a cohort study in the French national claims database: Long-term post-MI outcomes. Br J Clin Pharmacol. 2017;83(9):2056\u201365.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"554_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2016-000580","volume":"4","author":"SM Bradley","year":"2017","unstructured":"Bradley SM, Hess GP, Stewart P, et al. Implications of the PEGASUS-TIMI 54 trial for US clinical practice. Open Heart. 2017;4(1): e000580.","journal-title":"Open Heart"},{"issue":"24","key":"554_CR26","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1161\/CIRCULATIONAHA.113.001258","volume":"127","author":"E Braunwald","year":"2013","unstructured":"Braunwald E, Morrow DA. Unstable angina: is it time for a requiem? Circulation. 2013;127(24):2452\u20137.","journal-title":"Circulation"},{"issue":"10151","key":"554_CR27","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0140-6736(18)31923-8","volume":"392","author":"ASV Shah","year":"2018","unstructured":"Shah ASV, Anand A, Strachan FE, et al. High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial. Lancet. 2018;392(10151):919\u201328.","journal-title":"Lancet"},{"key":"554_CR28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ijcard.2018.11.138","volume":"278","author":"F Schiele","year":"2019","unstructured":"Schiele F, Puymirat E, Ferri\u00e8res J, et al. The FAST-MI 2005\u20132010-2015 registries in the light of the COMPASS trial: the COMPASS criteria applied to a post-MI population. Int J Cardiol. 2019;278:7\u201313.","journal-title":"Int J Cardiol"},{"issue":"9","key":"554_CR29","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1093\/eurheartj\/ehx658","volume":"39","author":"A Darmon","year":"2018","unstructured":"Darmon A, Bhatt DL, Elbez Y, et al. External applicability of the COMPASS trial: an analysis of the reduction of atherothrombosis for continued health (REACH) registry. Eur Heart J. 2018;39(9):750\u2013757a.","journal-title":"Eur Heart J"},{"issue":"4","key":"554_CR30","doi-asserted-by":"publisher","first-page":"786.e1","DOI":"10.1016\/j.ahj.2005.11.004","volume":"151","author":"EM Ohman","year":"2006","unstructured":"Ohman EM, Bhatt DL, Steg PG, et al. The REduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design. Am Heart J. 2006;151(4):786.e1-786.e10.","journal-title":"Am Heart J"},{"issue":"23","key":"554_CR31","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1161\/CIRCULATIONAHA.120.046448","volume":"141","author":"DL Bhatt","year":"2020","unstructured":"Bhatt DL, Eikelboom JW, Connolly SJ, et al. Role of combination antiplatelet and anticoagulation therapy in diabetes mellitus and cardiovascular disease: insights from the COMPASS trial. Circulation. 2020;141(23):1841\u201354.","journal-title":"Circulation"},{"issue":"3","key":"554_CR32","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","volume":"41","author":"J Knuuti","year":"2020","unstructured":"Knuuti J, Wijns W, Saraste A, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407\u201377.","journal-title":"Eur Heart J"},{"issue":"4","key":"554_CR33","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41569-019-0314-y","volume":"17","author":"D Capodanno","year":"2020","unstructured":"Capodanno D, Bhatt DL, Eikelboom JW, et al. Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease. Nat Rev Cardiol. 2020;17(4):242\u201357.","journal-title":"Nat Rev Cardiol"},{"issue":"14","key":"554_CR34","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1093\/eurheartj\/ehv531","volume":"37","author":"MP Bonaca","year":"2016","unstructured":"Bonaca MP, Bhatt DL, Steg PG, et al. Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y 12 inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54. Eur Heart J. 2016;37(14):1133\u201342.","journal-title":"Eur Heart J"},{"issue":"11","key":"554_CR35","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/j.jacc.2017.07.768","volume":"70","author":"MP Bonaca","year":"2017","unstructured":"Bonaca MP, Storey RF, Theroux P, et al. Efficacy and safety of ticagrelor over time in patients with prior MI in PEGASUS-TIMI 54. J Am Coll Cardiol. 2017;70(11):1368\u201375.","journal-title":"J Am Coll Cardiol"},{"issue":"10117","key":"554_CR36","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0140-6736(17)32458-3","volume":"391","author":"SJ Connolly","year":"2018","unstructured":"Connolly SJ, Eikelboom JW, Bosch J, et al. Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial. The Lancet. 2018;391(10117):205\u201318.","journal-title":"The Lancet"},{"key":"554_CR37","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ahj.2019.09.006","volume":"218","author":"RC Welsh","year":"2019","unstructured":"Welsh RC, Peterson ED, De Caterina R, Bode C, Gersh B, Eikelboom JW. Applying contemporary antithrombotic therapy in the secondary prevention of chronic atherosclerotic cardiovascular disease. Am Heart J. 2019;218:100\u20139.","journal-title":"Am Heart J"},{"issue":"10","key":"554_CR38","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1055\/s-0039-1679903","volume":"119","author":"W Sumaya","year":"2019","unstructured":"Sumaya W, Geisler T, Kristensen SD, Storey RF. Dual antiplatelet or dual antithrombotic therapy for secondary prevention in high-risk patients with stable coronary artery disease? Thromb Haemost. 2019;119(10):1583\u20139.","journal-title":"Thromb Haemost"}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-022-00554-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40256-022-00554-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-022-00554-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T12:08:08Z","timestamp":1673957288000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40256-022-00554-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,31]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["554"],"URL":"https:\/\/doi.org\/10.1007\/s40256-022-00554-5","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,31]]},"assertion":[{"value":"4 October 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MM curated the conceptualization, data curation, investigation, methodology, project administration, supervision, validation, visualization, writing, reviewing and editing of this article. EE curated the conceptualization and analysis. GM curated the conceptualization. FD\u2019A curated the supervision, validation and reviewing.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contributions"}},{"value":"No external funding was used in the preparation of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Michele Millesimo, Edoardo Elia, Giorgio Marengo, Fabrizio D\u2019Ascenzo and Gaetano Maria De Ferrari declare that they have no potential conflicts of interest that might be relevant to the contents of this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Provided from the different centers.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}